CIK 0001157075
- Non-accelerated filer
- Smaller reporting company
PharmaCyte Biotech, Inc.
Sign in to watch- Ticker
- PMCB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 621772151
- Phone
- +1 917-595-2850
- Business address
- 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS, NV, 89169
- Former names
- NUVILEX, INC., EFOODSAFETY COM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | WEINSTEIN ROBERT Director | Other acquisition · Stock Option (Right to Buy) | +0 | 0 | ||
| 2026-03-31 | WEINSTEIN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +119,170 | 119,170 | ||
| 2025-12-12 | WEINSTEIN ROBERT Director | Grant or award | +75,000 | 75,000 | ||
| 2025-12-12 | WEINSTEIN ROBERT Director | Shares withheld for taxes | −33,750 | $1.02 | $34K | 41,250 |
| 2025-04-25 | WEINSTEIN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +63,233 | 63,233 | ||
| 2024-04-30 | WEINSTEIN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +38,009 | 38,009 | ||
| 2023-11-20 | WEINSTEIN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +61,248 | 61,248 |
Page 1 of 1 · 7 trades